Western Growers & Wharf42 Initiative Platform 10 Launches Global Grower Trial Network To Speed Up Adoption Of Biologicals


In a significant move to accelerate the adoption of biologicals in agriculture, Western Growers and Wharf42 have announced the launch of Platform 10, a global grower trial network. This innovative initiative aims to connect growers, biological companies, and researchers to facilitate the testing and implementation of biological solutions in farming practices.

The increasing demand for sustainable and environmentally friendly farming practices has led to a growing interest in biologicals, which are natural, non-synthetic substances used to control pests, diseases, and improve crop yields. However, the adoption of biologicals has been hindered by the lack of data, limited access to trials, and the need for more research and development.

Platform 10 addresses these challenges by creating a global network of growers, researchers, and biological companies. The platform provides a collaborative space for these stakeholders to come together, share knowledge, and conduct trials on biological products. This will enable the development of more effective and targeted biological solutions, tailored to specific crop and region needs.

Accelerating Adoption of Biologicals

The launch of Platform 10 marks a significant step forward in the adoption of biologicals in agriculture. By providing a global trial network, the platform will facilitate the testing of biological products on a large scale, generating valuable data and insights that can inform farming practices.

“Platform 10 is a game-changer for the agricultural industry,” said Tom Nassif, President and CEO of Western Growers. “By connecting growers, researchers, and biological companies, we can accelerate the development and adoption of biological solutions, ultimately leading to more sustainable and productive farming practices.”

Benefits for Growers

Platform 10 offers numerous benefits for growers, including:

 Access to a global network of researchers, biological companies, and other growers
 Opportunities to participate in trials and testing of biological products
 Access to data and insights generated from trials, informing farming practices
 Potential to increase crop yields and reduce chemical usage

Benefits for Biological Companies

The platform also provides significant benefits for biological companies, including:

 Access to a global network of growers and researchers
 Opportunities to conduct large-scale trials and generate valuable data
 Ability to refine and improve biological products based on trial results
 Increased visibility and credibility in the market

A Collaborative Approach

Platform 10 is built on a collaborative approach, bringing together stakeholders from across the agricultural industry. By working together, growers, researchers, and biological companies can drive innovation and adoption of biological solutions.

“We are excited to launch Platform 10 and bring together the best minds in the industry,” said Peter Wren-Hilton, Founder of Wharf42. “By working collaboratively, we can accelerate the development and adoption of biological solutions, ultimately leading to a more sustainable and productive agricultural industry.”

The Future of Agriculture

The launch of Platform 10 marks a significant step forward in the future of agriculture. As the industry continues to evolve, the adoption of biological solutions will play a critical role in shaping a more sustainable and productive food system.

With Platform 10, Western Growers and Wharf42 are leading the charge in this evolution, providing a collaborative space for stakeholders to come together and drive innovation. As the platform grows and expands, it is likely to have a profound impact on the agricultural industry, shaping the future of farming practices and contributing to a more sustainable food system.


Please enter your comment!
Please enter your name here

Share post:




More like this

The Devil Wears Prada Is Reportedly Getting a Sequel

Fans of the iconic 2006 film "The Devil Wears...

Top Wall Street strategist explains why he’s abandoning an S&P 500 target

As Wall Street analysts and strategists are constantly adjusting...

Stocks are likely to see a 10% correction as earnings weaken and election uncertainty swirls, Morgan Stanley CIO says

Stock market investors should brace themselves for a potential...

51,200-Year-Old Painting in Indonesian Cave May Be Oldest Known Evidence of Storytelling in Art

A recent discovery in an Indonesian cave has archaeologists...